This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Willfactin (EU), WILFACTIN, Willfact
Description: Wilfact is a very high purity plasma derived human von Willebrand factor (vWF) concentrate.
LFB and Swedish Orphan Biovitrum
Sobi will, under the agreement with LFB BIOMEDICAMENTS, distribute Willfact in Germany, Sweden, Norway, Denmark, Estonia, Latvia, Lithuania, Slovenia, Czech Republic, Slovakia and Hungary.
Partners: Swedish Orphan Biovitrum
Pink Sheet Chart: Weekly Trademark Review
Additional information available to subscribers only: